Iantrek raises $23M

Medical device company Iantrek has closed on $23 million of series B financing.

Iantrek specializes in ophthalmic devices and technology. The new financing will be used for clinical introduction and further studies of Iantrek's micro-interventional glaucoma surgical devices, according to an Aug. 30 Iantrek news release.

"There remains a significant unmet clinical need to provide safe and effective micro-interventional tools for aqueous outflow management," said Sean Ianchulev, MD, founder of Iantrek. "We are grateful to have a world-class syndicate of investors supporting our efforts to advance these new technologies. With two commercially ready MIGS platforms, Iantrek is uniquely positioned to transform the horizon of micro-interventional ophthalmic surgery."

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars